Skip to main content

Correction to: Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer’s disease, but not in cerebral amyloid angiopathy

The Original Article was published on 24 September 2021

Correction to: Alz Res Therapy 13, 160 (2021)

https://doi.org/10.1186/s13195-021-00899-0

Following the publication of the original article [1] the authors noticed that the published Fig. 2 is incorrect. The authors uploaded the incorrect figure during the proofing process. The original article [1] has been updated. The correct Fig. 2 is depicted below.  

Fig. 2
figure1

A ROC analysis showed moderately high accuracy levels for discrimination of aMCI from control in the Nijmegen aMCI patients and controls (gray line) and the Barcelona aMCI patients and controls (black line). B ROC analysis showed consistently high accuracy levels for discrimination of AD from control in the Nijmegen AD patients and controls (gray line) and the Barcelona AD patients and controls (black line). Abbreviations: AD, Alzheimer’s disease; AUC area under the curve. The Barcelona cohort serves as a validation cohort

Reference

  1. 1.

    De Kort AM, Kuiperij HB, Alcolea D, et al. Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer’s disease, but not in cerebral amyloid angiopathy. Alz Res Therapy. 2021;13:160. https://doi.org/10.1186/s13195-021-00899-0.

    Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Marcel M. Verbeek.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

De Kort, A.M., Kuiperij, H.B., Alcolea, D. et al. Correction to: Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer’s disease, but not in cerebral amyloid angiopathy. Alz Res Therapy 13, 189 (2021). https://doi.org/10.1186/s13195-021-00929-x

Download citation